Social Egg Freezing: Will Health Professionals Offer it ?

July 26, 2024 updated by: Centre Hospitalier Universitaire de Saint Etienne
In 2021, the revision of bioethics laws opened the door to elective egg freezing. This gives women, between their 29th and 37th birthdays, the opportunity to freeze their eggs in order to combat age decline fertility. However, communication about this new possibility has remained limited both toward women and their health professional.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Thus, the hypothesize of this study is that these professionals, namely physicians, gynecologists and midwives, are insufficiently aware of age-related fertility decline and unaware of the possibility of elective egg freezing.

This multicenter observational cross-sectional study whose objective will be:

  • To assess the knowledge of these professionals in terms of age-related fertility decline.
  • To measure their propensity to spontaneously broach the subject with their childless patients.
  • To assess their knowledge and support for elective egg freezing. This study will be done using an online questionnaire that will be distributed in electronic format to all the health professionals concerned in the participating areas.

This study will provide valuable knowledge on the perception of elective egg freezing by health professionals, determine their training needs and motivate new information campaigns on this subject.

Study Type

Observational

Enrollment (Estimated)

2500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • France
      • Saint-Étienne, France, 42000
        • Recruiting
        • CHU Saint Etienne
        • Principal Investigator:
          • Jean-Philippe KLEIN, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Practising GPs, gynaecologists or midwives

Description

Inclusion Criteria:

  • Be a general practitioner, gynecologist or midwife in practice for at least one year
  • Follow patients between 29 and 37 years old (for their contraception for example)

Exclusion Criteria:

  • Have been practising for less than a year
  • Have no patients aged between 29 and 37

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Health professionals
General practitioner, gynecologist or midwife
Other: Online questionnaire
An online questionnaire will be distributed in electronic format to all the healthcare professionals concerned.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knowledge of primary care professionals regarding age-related decline in fertility.
Time Frame: Day 1
Analysis questionnaire results.
Day 1
Propensity to spontaneously broach the subject with their patients without children.
Time Frame: Day 1
Analysis questionnaire results.
Day 1
Knowledge and support for the elective egg freezing.
Time Frame: Day 1
Analysis questionnaire results.
Day 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Centre Hospitalier Universitaire de Saint Etienne

Investigators

  • Principal Investigator: Jean-Philippe KLEIN, MD, CHU Saint Etienne

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2024

Primary Completion (Estimated)

February 1, 2025

Study Completion (Estimated)

February 1, 2025

Study Registration Dates

First Submitted

July 26, 2024

First Submitted That Met QC Criteria

July 26, 2024

First Posted (Actual)

July 31, 2024

Study Record Updates

Last Update Posted (Actual)

July 31, 2024

Last Update Submitted That Met QC Criteria

July 26, 2024

Last Verified

July 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • IRBN942023/CHUSTE

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Infertility,Female

Clinical Trials on Online questionnaire

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sri Lanka

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe